View Post

Mammograms not catching worst cancers before they spread – US study

In In The News by Barbara Jacoby

From: theguardian.com A new report has raised fresh questions about the value of mammograms, with the United States recording no reduction in the rate of cancers that have already spread far beyond the breast before they are found. The report, in Thursday’s New England Journal of Medicine, is by three cancer specialists and is based on federal statistics going back …

View Post

Metastatic breast cancer patients receive support online

In In The News by Barbara Jacoby

By: Denise Dador From: abc7.com Experts estimate at least 150,000 women are living with metastatic breast cancer. For most, that means lifelong treatment to keep the disease at bay. It can be extremely isolating; often, family and friends just don’t understand. Now, local researchers have found a way to help: giving women a way to reach out online to get …

View Post

Advanced Breast Cancer: What Happens Next?

In In The News by Barbara Jacoby

By: Stephanie Pierce From: healthline.com Get a sense of your treatment and support options going forward. A diagnosis of stage 4 breast cancer can be overwhelming. Not only must you deal with the many thoughts and emotions competing for space inside your head, but the sheer number of available treatment options can boggle the mind. Stage 4: What Does It …

View Post

A Biological Quest Leads To A New Kind Of Breast Cancer Drug

In In The News by Barbara Jacoby

By: Richard Harris From: npr.org Each year, the Food and Drug Administration approves dozens of drugs, but often those medicines don’t make a huge difference to people with disease. That’s because these “new” drugs are often very much like existing medicines — or are, in fact, existing medicines, approved for a slightly different purpose. But every now and then the …

View Post

Analysts: Pfizer’s New Type of Cancer Drug May Get OK Early

In In The News by Barbara Jacoby

By Linda a. Johnson From: AP As shared on: yahoo.com The first in a new class of cancer medicines, Pfizer’s Ibrance, appears poised for approval to treat advanced breast cancer within a few months and could quickly become a blockbuster, some analysts believe. Pfizer shares rose 74 cents, or 2.3 percent, to $32.59 Thursday following analysts’ forecasts that the U.S. …

Certain Advanced Breast Cancer Patients May Benefit From Surgery Before Other Treatment

In In The News by Barbara Jacoby

From: gantdaily.com Patients newly diagnosed with advanced breast cancer and a solitary bone metastasis could benefit from surgery prior to other treatment, according to early results from a first-of-its kind clinical trial presented recently at the 2013 San Antonio Breast Cancer Symposium. “In the United States, approximately 5 percent of breast cancer patients are diagnosed with advanced disease when they …